文献速递妇科

子宫癌患者林奇综合征普遍筛查的质量改进项目

Universal screening for Lynch syndrome in uterine cancer patients: A quality improvement initiative.
PubMed 文献 · Gynecol Oncol · 2020-10-21

该质量改进项目在既往按年龄筛查的机构中,对全部子宫癌标本实施普遍错配修复缺陷(MMR)和微卫星不稳定(MSI)检测,并配套培训、标准化记录和电子病历优化。实施后≤60岁患者筛查率从57.7%升至94.5%,全部患者从38.4%升至94.5%,异常结果转遗传转诊率从20.0%升至36.4%,胚系诊断从1.1%升至2.2%。

要点

  • 普遍筛查使全部子宫癌患者筛查率从38.4%提升至94.5%。
  • ≤60岁患者筛查率从57.7%提升至94.5%。
  • 异常筛查结果转遗传转诊率从20.0%提升至36.4%。

核心结论

  • 通过提供者教育、优化电子病历使用和简化筛查指征,筛查指南依从性显著改善。
  • 这些干预措施在其他机构可行,并可推广至其他筛查指征。

研究设计与样本

  • 质量改进项目,比较实施前(190例)与实施后(182例)子宫癌患者的筛查率、结果、异常随访和最终诊断。
  • 实施前对诊断年龄≤60岁患者进行MMR和MSI筛查,实施后对所有子宫癌标本普遍检测。

主要发现

  • ≤60岁患者筛查率从45/78(57.7%)升至64/68(94.5%)。
  • 全部患者筛查率从73/190(38.4%)升至172/182(94.5%)。
  • 异常筛查结果从15/190(7.9%)升至44/182(24.0%)。
  • 筛查阳性者遗传转诊率从3/15(20.0%)升至16/44(36.4%)。
  • 胚系诊断从2/190(1.1%,2例林奇综合征)升至4/182(2.2%,3例林奇综合征和1例BRCA1胚系诊断)。

关键数值与推荐

  • 实施前对诊断年龄≤60岁患者筛查MMR和MSI,实施后对所有子宫癌标本普遍检测。
  • 干预包括提供者培训、标准化记录和增强电子病历使用。

临床怎么用

  • 对全部子宫癌标本实施普遍MMR/MSI筛查,并配套培训、标准化记录和电子病历优化。
  • 对筛查异常者及时转遗传咨询,以提高林奇综合征检出。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the feasibility and effectiveness of a quality improvement initiative (QI) to adopt universal screening for Lynch syndrome in uterine cancer patients at an institution that previously employed age-based screening. METHODS: Prior to the initiative, tumors of patients with uterine cancer diagnosed at age ≤ 60 years were screened for mismatch repair deficiency (MMR) and microsatellite instability (MSI). The QI process change model adopted universal testing of all uterine cancer specimens and implemented provider training, standardized documentation, and enhanced use of the electronic medical record (EMR). We compared screening rates, results of screening, follow up of abnormal results, and final diagnoses from the pre- and post-implementation periods. RESULTS: Pre- and post-implementation screening rates for women age ≤ 60 years at the time of diagnosis were 45/78 (57.7%) and 64/68 (94.5%), respectively. The screening rate for all patients with uterine cancer increased from 73/190 (38.4%) to 172/182 (94.5%). The rate of abnormal screening results increased from 15/190 (7.9%) to 44/182 (24.0%) cases. Genetics referral rates among screen positives increased from 3/15 (20.0%) to 16/44 (36.4%). Germline diagnoses increased from 2/190 (1.1%) with two Lynch syndrome diagnoses to 4/182 (2.2%) including three Lynch syndrome diagnoses and one BRCA1 germline diagnosis. The number of patients errantly not screened decreased from at least 32 patients to 3 patients after the intervention. CONCLUSIONS: Adherence to screening guidelines significantly improved after interventions involving provider education, optimal use of the EMR, and simplification of screening indications. These interventions are feasible at other institutions and translatable to other screening indications.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Spinosa D, Acosta T, Wong J, et al. Universal screening for Lynch syndrome in uterine cancer patients: A quality improvement initiative. Gynecol Oncol. 2020. PMID: 33393478. doi:10.1016/j.ygyno.2020.10.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。